Fasihul Khan
The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): Description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease
Khan, Fasihul; Stewart, Iain; Howard, Lucy; McKeever, Tricia; Jones, Steve; Hearson, Glenn; Braybrooke, Rebecca; Edwards, Colin; Jenkins, Gisli; Saini, Gauri
Authors
Iain Stewart
Lucy Howard
TRICIA MCKEEVER tricia.mckeever@nottingham.ac.uk
Professor of Epidemiology and Medical Statistics
Steve Jones
Glenn Hearson
Rebecca Braybrooke
Colin Edwards
Gisli Jenkins
Gauri Saini
Abstract
Introduction: The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS) is a multicentre, prospective, observational cohort study. The aims of this study are to identify genetic, serum and other biomarkers that may identify specific molecular mechanisms, reflecting disease endotypes that are shared among patients with progressive pulmonary fibrosis regardless of aetiology. Furthermore, it is anticipated that these biomarkers will help predict fibrotic activity that may identify patterns of disease behaviour with greater accuracy than current clinical phenotyping.
Methods and analysis: 200 participants with the multidisciplinary team confirmed fibrotic lung disease (50 each of rheumatoid-interstitial lung disease (ILD), asbestosis, chronic hypersensitivity pneumonitis and unclassifiable ILD) and 50 idiopathic pulmonary fibrosis participants, recruited as positive controls, will be followed up for 2 years. Participants will have blood samples, lung function tests, quality of life questionnaires and a subgroup will be offered bronchoscopy. Participants will also be given the option of undertaking blinded home handheld spirometry for the first 3 months of the study. The primary end point will be identification of a biomarker that predicts disease progression, defined as 10% relative change in forced vital capacity (FVC) or death at 12 months.
Ethics and dissemination: The trial has received ethical approval from the National Research Ethics Committee Nottingham (18/EM/0139). All participants must provide written informed consent. The trial will be overseen by the INJUSTIS steering group that will include a patient representative, and an independent chairperson. The results from this study will be submitted for publication in peer-reviewed journals and disseminated at regional and national conferences.
Trial registration number NCT03670576
Citation
Khan, F., Stewart, I., Howard, L., McKeever, T., Jones, S., Hearson, G., …Saini, G. (2019). The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): Description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease. BMJ Open Respiratory Research, 6(1), 1-7. https://doi.org/10.1136/bmjresp-2019-000439
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 26, 2019 |
Online Publication Date | Jun 4, 2019 |
Publication Date | Jun 4, 2019 |
Deposit Date | May 14, 2019 |
Publicly Available Date | Jun 25, 2019 |
Journal | BMJ Open Respiratory Research |
Electronic ISSN | 2052-4439 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 6 |
Issue | 1 |
Article Number | e000439 |
Pages | 1-7 |
DOI | https://doi.org/10.1136/bmjresp-2019-000439 |
Public URL | https://nottingham-repository.worktribe.com/output/2048335 |
Publisher URL | https://bmjopenrespres.bmj.com/content/6/1/e000439 |
Files
The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS)
(591 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/